Join to view full profile
200 West Arbor Dr Mc 0949Ucsd Medical CenterSan Diego, CA 92103
Phone+1 858-622-2028
Dr. Aisen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1979 - 1982
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979, MD
Certifications & Licensure
CA State Medical License 2008 - 2027
DC State Medical License 1999 - 2010
VA State Medical License 1999 - 2002
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Author Correction: Sex-specific biological aging clocks across organs and omics., Zhiyuan Song, Derek Fong, Naowal Azraf Rahman, Michael R Duggan
Nature Medicine. 2026-10-26 - EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.Thiago Paranhos, Yuta Katsumi, Michael Joseph Brickhouse, Ani Eloyan, Ryan Eckbo
Neurology. 2026-10-13 - Sex-specific biological aging clocks across organs and omics., Zhiyuan Song, Derek Fong, Naowal Azraf Rahman, Michael R Duggan
Nature Medicine. 2026-09-16
Press Mentions
University of Maryland School of Medicine Launches Groundbreaking Study on THC/CBD Therapy for Dementia-Related Agitation at End of LifeJuly 10th, 2025- Will Alzheimer’s Disease Become Preventable Within a Decade? Researchers from USC ATRI Say ‘Yes’June 20th, 2025
- Small Study Hints Anti-Amyloid Therapy May Keep Alzheimer’s Symptoms at Bay in Certain PatientsMarch 21st, 2025
Grant Support
- The Ante-Amyloid Treatment of Alzheimer's disease (A3) Trial and Alzheimer Plasma EXtension (APEX) StudyBRIGHAM AND WOMEN'S HOSPITAL2025–2030
- Life’s end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) StudyMEDICAL UNIVERSITY OF SOUTH CAROLINA2025–2028
- Alzheimer's Clinical Trials Consortium (ACTC)UNIVERSITY OF SOUTHERN CALIFORNIA2017–2028
- Alzheimer's Clinical Trials Consortium (ACTC)UNIVERSITY OF SOUTHERN CALIFORNIA2017–2028
- Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 MonthsCOGNITION THERAPEUTICS, INC.2020–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: